
HilleVax, Inc.
USD2.09
-0.01 (-0.48%)
CEO
Robert M. Hershberg
IPO Date
2022-04-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.09
Prev. Close
$2.10
Day Low
$2.09
Day High
$2.09
52W Low
$1.34
52W High
$2.17
Market Cap
$0.10B
Volume
2.80M
| 9 Jul 2024 |
| Leerink Partners |
| Outperform |
| Market Perform |
| downgrade |
| 9 Jul 2024 | Stifel | Buy | Hold | downgrade |
| 8 Jul 2024 | Guggenheim | Buy | Neutral | downgrade |
| 8 Jul 2024 | JP Morgan | Overweight | Neutral | downgrade |
| 15 May 2024 | JP Morgan | Overweight | Overweight | maintain |
| 10 May 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 21 Mar 2024 | HC Wainwright & Co. | Buy | Buy | maintain |